rs3195678

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014324.6(AMACR):​c.782T>C​(p.Met261Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00218 in 1,614,186 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M261I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 40 hom. )

Consequence

AMACR
NM_014324.6 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.25

Publications

5 publications found
Variant links:
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002657652).
BP6
Variant 5-33989460-A-G is Benign according to our data. Variant chr5-33989460-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235412.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0119 (1820/152316) while in subpopulation AFR AF = 0.0422 (1752/41556). AF 95% confidence interval is 0.0405. There are 47 homozygotes in GnomAd4. There are 856 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMACRNM_014324.6 linkc.782T>C p.Met261Thr missense_variant Exon 5 of 5 ENST00000335606.11 NP_055139.4 Q9UHK6-1
AMACRNM_001167595.2 linkc.782T>C p.Met261Thr missense_variant Exon 5 of 6 NP_001161067.1 Q9UHK6-5
C1QTNF3-AMACRNR_037951.1 linkn.1138T>C non_coding_transcript_exon_variant Exon 9 of 9
AMACRNM_203382.3 linkc.*24T>C 3_prime_UTR_variant Exon 4 of 4 NP_976316.1 Q9UHK6-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMACRENST00000335606.11 linkc.782T>C p.Met261Thr missense_variant Exon 5 of 5 1 NM_014324.6 ENSP00000334424.6 Q9UHK6-1
C1QTNF3-AMACRENST00000382079.3 linkn.*208T>C non_coding_transcript_exon_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6
C1QTNF3-AMACRENST00000382079.3 linkn.*208T>C 3_prime_UTR_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6

Frequencies

GnomAD3 genomes
AF:
0.0119
AC:
1805
AN:
152198
Hom.:
46
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0419
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.00287
AC:
721
AN:
251300
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.0393
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.00116
AC:
1703
AN:
1461870
Hom.:
40
Cov.:
34
AF XY:
0.00102
AC XY:
741
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0424
AC:
1418
AN:
33480
American (AMR)
AF:
0.00197
AC:
88
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1112006
Other (OTH)
AF:
0.00227
AC:
137
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
94
187
281
374
468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0119
AC:
1820
AN:
152316
Hom.:
47
Cov.:
33
AF XY:
0.0115
AC XY:
856
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0422
AC:
1752
AN:
41556
American (AMR)
AF:
0.00288
AC:
44
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68028
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
89
178
268
357
446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00478
Hom.:
28
Bravo
AF:
0.0135
ESP6500AA
AF:
0.0372
AC:
164
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00372
AC:
452
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 19, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 17, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Alpha-methylacyl-CoA racemase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 24, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital bile acid synthesis defect 4;C3280428:Alpha-methylacyl-CoA racemase deficiency Benign:1
Oct 08, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.82
DANN
Benign
0.53
DEOGEN2
Benign
0.052
T;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.41
T;T;T
MetaRNN
Benign
0.0027
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L;L;.
PhyloP100
1.2
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Benign
0.050
Sift
Benign
0.75
T;T;T
Sift4G
Benign
0.70
T;T;T
Polyphen
0.0090
B;.;B
Vest4
0.012
MVP
0.20
MPC
0.061
ClinPred
0.0062
T
GERP RS
-5.4
Varity_R
0.025
gMVP
0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3195678; hg19: chr5-33989565; COSMIC: COSV99031127; COSMIC: COSV99031127; API